Skip to main content
SpringerLink
Log in

Pancreatic Incidentaloma

  • Chapter
  • First Online:
Endocrine Surgery

Part of the book series: Springer Specialist Surgery Series ((SPECIALIST))

The widespread use of highly sensitive imaging techniques has led to the serendipitous identification of subclinical tumors in some organs [1]. Pancreatic incidentaloma (PI) has been defined as a mass that is incidentally discovered during an image study for symptoms other than the ones of the mass itself or the organ affected. The term “pancreatic incidentaloma” was first described by Ho and Kostiuk [2, 3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Prinz RA, Brooks MH, Churchill R, et al. Incidental asymptomatic adrenal masses detected by computed tomographic scanning. Is operation required? JAMA. 1982;248:701–4.

    Article  PubMed  CAS  Google Scholar 

  2. Kostiuk TS. Observation of pancreatic incidentaloma. Klin Khir. 2001;9:62–3.

    PubMed  Google Scholar 

  3. Ho CL, Dehdashti F, Griffeth LK, et al. FDG-PET evaluation of indeterminate pancreatic masses. J Comput Assist Tomogr. 1996;20:363–9.

    Article  PubMed  CAS  Google Scholar 

  4. Strang AM, Lockhart ME, Kenney PJ, et al. Computerized tomographic angiography for renal donor evaluation leads to a higher exclusion rate. J Urol. 2007;177:1826–9.

    Article  PubMed  Google Scholar 

  5. Ide M, Suzuki Y. Is whole-body FDG-PET valuable for health screening? Eur J Nucl Med Mol Imaging. 2005;32:339–41.

    Article  PubMed  Google Scholar 

  6. Winter JM, Cameron JL, Lillemoe KD, et al. Periampullary and pancreatic incidentaloma: a single institution’s experience with an increasingly common diagnosis. Ann Surg. 2006;243:673–80.

    Article  PubMed  Google Scholar 

  7. Tsui KH, Shvarts O, Smith RB, et al. Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol. 2000;163:426–30.

    Article  PubMed  CAS  Google Scholar 

  8. Little JM, Richardson A, Tait N. Hepatic dystychoma: a five year experience. HPB Surg. 1991;4:291–7.

    Article  PubMed  CAS  Google Scholar 

  9. Liu CL, Fan ST, Lo CM, et al. Hepatic resection for incidentaloma. J Gastrointest Surg 2004;8:785–93.

    Article  PubMed  Google Scholar 

  10. Westbrook JI, Braithwaite J, McIntosh JH. The outcomes for patients with incidental lesions: serendipitous or iatrogenic? Am J Roetnol. 1998;171:1193–6.

    CAS  Google Scholar 

  11. Herrera MF, Grant CS, van Heerden JA, et al. Incidentally discovered adrenal tumors: an institutional perspective. Surgery. 1991;110:1014–21.

    PubMed  CAS  Google Scholar 

  12. Wolfson D, Barkin JS, Chari ST, et al. Management of pancreatic masses. Pancreas. 2005;31:203–17.

    Article  PubMed  Google Scholar 

  13. Steer ML, Waxman I, Freedman S. Chronic pancreatitis. N Engl J Med. 1995;332:1482–90.

    Article  PubMed  CAS  Google Scholar 

  14. Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. N Engl J Med. 2006;355:2670–6.

    Article  PubMed  CAS  Google Scholar 

  15. Yadav D, Notahara K, Smyrk TC, et al. Idiopathic tumefactive chronic pancreatitis: clinical profile, histology, and natural history after resection. Clin Gastroenterol Hepatol. 2003;1:129–35.

    Article  PubMed  Google Scholar 

  16. Hammel P. Tumeurs pancréatiques de découverte fortuite: diagnostic et prise en charge. Gastroenterol Clin Biol. 2002;26:700–8.

    PubMed  Google Scholar 

  17. Gangi S, Fletcher JG, Nathan MA, et al. Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. AJR Am J Roentgenol. 2004;182:897–903.

    PubMed  Google Scholar 

  18. McMahon PM, Halpern EF, Fernandez-del Castillo C, et al. Pancreatic cancer: cost-effectiveness of imaging technologies for assessing resectability. Radiology. 2001;221:93–106.

    Article  PubMed  CAS  Google Scholar 

  19. Nichols MT, Russ PD, Chen YK. Pancreatic imaging: current and emerging technologies. Pancreas. 2006;33:211–20.

    Article  PubMed  Google Scholar 

  20. Saisho H, Yamaguchi T. Diagnostic imaging for pancreatic cancer: computed tomography, magnetic resonance imaging, and positron emission tomography. Pancreas. 2004;28:273–8.

    Article  PubMed  Google Scholar 

  21. Choi EK, Park SH, Kim DY, et al. Unusual manifestations of primary pancreatic neoplasia: radiologic-pathologic correlation. J Comput Assist Tomogr. 2006;30:610–7.

    Article  PubMed  Google Scholar 

  22. Delbeke D, Pinson CW. Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment. J Hepatobiliary Pancreat Surg. 2004;11:4–10.

    Article  PubMed  Google Scholar 

  23. Kalra MK, Maher MM, Boland GW, et al. Correlation of positron emission tomography and CT in evaluating pancreatic tumors: technical and clinical implications. AJR Am J Roentgenol. 2003;181:387–93.

    PubMed  Google Scholar 

  24. Lopez Hänninen E, Amthauer H, Hosten N, et al. Prospective evaluation of pancreatic tumors: accuracy of MR Imaging with MR cholangiopancreatography and MR Angiography. Radiology. 2002;224:34–41.

    Article  PubMed  Google Scholar 

  25. Tajima Y, Kuroki T, Tsutsumi R, et al. Pancreatic carcinoma coexisting with chronic pancreatitis versus tumor-forming pancreatitis: diagnostic utility of the time-signal intensity curve from dynamic contrast-enhanced MR imaging. World J Gastroenterol. 2007;13:858–65.

    PubMed  Google Scholar 

  26. Horwhat JD, Gress FG. Defining the diagnostic algorithm in pancreatic cancer. JOP. 2004;5:289–303.

    PubMed  Google Scholar 

  27. Bhutani MS, Gress FG, Giovannini M, et al. The no endosonographic detection of tumor (NEST) study: a case series of pancreatic cancers missed on endoscopic ultrasonography. Endoscopy. 2004;36:385–9.

    Article  PubMed  CAS  Google Scholar 

  28. DeWitt J, Devereaux B, Chriswell M, et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med. 2004;141:753–63.

    PubMed  Google Scholar 

  29. Borbath I, Van Beers BE, Lonneux M, et al. Preoperative assessment of pancreatic tumors using magnetic resonance imaging, endoscopic ultrasonography, positron emission tomography and laparoscopy. Pancreatology. 2005;5:553–61.

    Article  PubMed  Google Scholar 

  30. Horwhat JD, Paulson EK, McGrath K, et al. A randomized comparison of EUS-guided FNA versus CT or US-guided FNA for the evaluation of pancreatic mass lesions. Gastrointest Endosc. 2006;63:966–75.

    Article  PubMed  Google Scholar 

  31. Voss M, Hammel P, Molas G, et al. Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses. Gut. 2000;46:244–9.

    Article  PubMed  CAS  Google Scholar 

  32. Varadarajulu S, Tamhane A, Eloubeidi MA. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Gastrointest Endosc. 2005;62:728–36.

    Article  PubMed  Google Scholar 

  33. Cwik G, Wallner G, Skoczylas T, et al. Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. Arch Surg. 2006;141:968–74.

    Article  PubMed  Google Scholar 

  34. Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007;297:1901–8.

    Article  PubMed  CAS  Google Scholar 

  35. Koopmann J, Zhang Z, White N, et al. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res. 2004;10:860–8.

    Article  PubMed  CAS  Google Scholar 

  36. Buchholz M, Kestler HA, Bauer A, et al. Specialized DNA arrays for the differentiation of pancreatic tumors. Clin Cancer Res. 2005;11:8048–54.

    Article  PubMed  CAS  Google Scholar 

  37. Honda K, Hayashida Y, Umaki T, et al. Possible detection of pancreatic cancer by plasma protein profiling. Cancer Res. 2005;65:10613–22.

    Article  PubMed  CAS  Google Scholar 

  38. Brentjens R, Saltz L. Islet cell tumor of the pancreas: the medical oncologist’s perspective. Surg Clin North Am. 2001;3,527–42.

    Article  Google Scholar 

  39. Horton KM, Hruban RH, Yeo C, Fishman EK. Multi-detector row CT of pancreatic islet cell tumors. Radiographics. 2006;26:453–64.

    Article  PubMed  Google Scholar 

  40. Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev. 2004;25:458–511.

    Article  PubMed  CAS  Google Scholar 

  41. Debray MP, Geoffroy O, Laissy JP, et al. Imaging appearances of metastases from neuroendocrine tumours of the pancreas. Br J Radiol. 2001;74:1065–70.

    PubMed  CAS  Google Scholar 

  42. Thoeni RF, Mueller-Lisse UG, Chan R, et al. Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology. 2000;214:483–90.

    PubMed  CAS  Google Scholar 

  43. Semelka RC, Custodio CM, Cem-Balci N, Woosley JT. Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. J Magn Reson Imaging. 2000;11:141–8.

    Article  PubMed  CAS  Google Scholar 

  44. Rösch T, Lightdale CJ, Botet JF, et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med. 1992;326:1721–6.

    Article  PubMed  Google Scholar 

  45. Anderson MA, Carpenter S, Thompson NW, et al. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol. 2000:95:2271–7.

    Article  PubMed  CAS  Google Scholar 

  46. Kaltsas GA, Mukherjee JJ, Grossman AB. The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours. Ann Oncol. 2001;12(Suppl 2):S47–50.

    Article  PubMed  Google Scholar 

  47. Wiedenmann B, Jensen RT, Mignon M, et al. Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumors: general recommendations by a consensus workshop. World J Surg. 1998;22:309–18.

    Article  PubMed  CAS  Google Scholar 

  48. Orlefors H, Sundin A, Garske U, et al. Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab. 2005;90:3392–400.

    Article  PubMed  CAS  Google Scholar 

  49. Merkle EM, Boaz T, Kolokythas O, et al. Metastases to the pancreas. Br J Radiol. 1998;71:1208–14.

    PubMed  CAS  Google Scholar 

  50. Scatarige JC, Horton KM, Sheth S, Fishman EK. Pancreatic parenchymal metastases: observations on helical CT. AJR Am J Roentgenol. 2001;176:695–9.

    PubMed  CAS  Google Scholar 

  51. Palazzo L, Borotto E, Cellier C, et al. Endosonographic features of pancreatic metastases. Gastrointest Endosc. 1996;44:433–6.

    Article  PubMed  CAS  Google Scholar 

  52. Ghavamian R, Klein KA, Stephens DH, et al. Renal cell carcinoma metastatic to the pancreas: clinical and radiological features. Mayo Clin Proced. 2000;75:581–5.

    Article  CAS  Google Scholar 

  53. Kim T, Murakami T, Takamura M, et al. Pancreatic mass due to chronic pancreatitis: correlation of CT and MR imaging features with pathologic findings. AJR Am J Roentgenol. 2001;177:367–71.

    PubMed  CAS  Google Scholar 

  54. Kwon RS, Brugge WR. New advances in pancreatic imaging. Curr Opin Gastroenterol. 2005;21:561–7.

    Article  PubMed  Google Scholar 

  55. Imdahl A. Nitzsche E, Krautmann F, et al. Evaluation of positron emission tomography with 2-[(18) F] fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer. Br J Surg. 1999;86:194–9.

    Article  PubMed  CAS  Google Scholar 

  56. Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41:626–31.

    Article  PubMed  Google Scholar 

  57. Fernández-del Castillo C, Targarona J, Thayer SP, et al. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg. 2003;138:427–34.

    Article  PubMed  Google Scholar 

  58. Allen PJ, Jaques DP, D’Angelica M, et al. Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients. J Gastrointest Surg. 2003;7:970–7.

    Article  PubMed  Google Scholar 

  59. Allen PJ, D'Angelica M, Gonen M, et al. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg. 2006;244:572–82.

    PubMed  Google Scholar 

  60. Sheehan MK, Beck K, Pickleman J, Aranha GV. Spectrum of cystic neoplasms of the pancreas and their surgical management. Arch Surg. 2003;138:657–62.

    Article  PubMed  Google Scholar 

  61. Sahani DV, Kadavigere R, Saokar A, et al. Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics. 2005;25:1471–84.

    Article  PubMed  Google Scholar 

  62. Holzheimer RG, Mannick JA (eds). Surgical treatment: evidence-based and problem-oriented. Munich, Germany: Zuckschwerdt, 2001.

    Google Scholar 

  63. Cohen-Scali F, Vilgrain V, Brancatelli G, et al. Discrimination of unilocular macrocystic serous cystadenoma from pancreatic pseudocyst and mucinous cystadenoma with CT: initial observations. Radiology. 2003;228:727–33.

    Article  PubMed  Google Scholar 

  64. Sarr MG, Murr M, Smyrk TC, et al. Primary cystic neoplasms of the pancreas. Neoplastic disorders of emerging importance-current state-of-the-art and unanswered questions. J Gastrointest Surg. 2003;7:417–28.

    Article  PubMed  Google Scholar 

  65. Curry CA, Eng J, Horton KM, et al. CT of primary cystic pancreatic neoplasms: can CT be used for patient triage and treatment? AJR Am J Roentgenol. 2000;175:99–103.

    PubMed  CAS  Google Scholar 

  66. Fernandez-del Castillo C, Warshaw AL. Current management of cystic neoplasms of the pancreas. Adv Surg. 2000;34:237–48.

    PubMed  CAS  Google Scholar 

  67. Procacci C, Biasiutti C, Carbognin G, et al. Characterization of cystic tumors of the pancreas: CT accuracy. J Comput Assist Tomogr. 1999;23:906–12.

    Article  PubMed  CAS  Google Scholar 

  68. Procacci C, Graziani R, Bicego E, et al. Serous cystadenoma of the pancreas: report of 30 cases with emphasis on imaging findings. J Comput Assist Tomogr. 1997;21:373–82.

    Article  PubMed  CAS  Google Scholar 

  69. Warshaw AL, Compton CC, Lewandrowski K, et al. Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients. Ann Surg. 1990;212:432–43.

    Article  PubMed  CAS  Google Scholar 

  70. Sahani D, Prasad S, Saini S, Mueller P. Cystic pancreatic neoplasms evaluation by CT and magnetic resonance cholangiopancreatography. Gastrointest Endosc Clin N Am. 2002;12:657–72.

    Article  PubMed  Google Scholar 

  71. Mathieu D, Guigui B, Valette PJ, et al. Pancreatic cystic neoplasms. Radiol Clin North Am. 1989;27:163–76.

    PubMed  CAS  Google Scholar 

  72. Horvath KD, Chabot JA. An aggressive resectional approach to cystic neoplasms of the pancreas. Am J Surg. 1999;178:269–74.

    Article  PubMed  CAS  Google Scholar 

  73. McNulty NJ, Francis IR, Platt JF, et al. Multi–detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology. 2001;220:97–102.

    PubMed  CAS  Google Scholar 

  74. Siech M, Tripp K, Schmidt-Rohlfing B, et al. Intraductal papillary mucinous tumor of the pancreas. Am J Surg. 1999;177:117–20.

    Article  PubMed  CAS  Google Scholar 

  75. Taouli B, Vilgrain V, Vullierme MP, et al. Intraductal papillary mucinous tumors of the pancreas: helical CT with histopathologic correlation. Radiology. 2000;217:757–64.

    PubMed  CAS  Google Scholar 

  76. Kloppel G, Kosmahl M. Cystic lesions and neoplasms of the pancreas: the features are becoming clearer. Pancreatology. 2001;1:648–55.

    Article  PubMed  CAS  Google Scholar 

  77. Mallery S, Quirk D, Lewandrowski K, et al. EUS-guided FNA with cyst fluid analysis in pancreatic cystic lesions (abstr). Gastrointest Endosc. 1998;47:AB149.

    Google Scholar 

  78. Brugge WR. Evaluation of pancreatic cystic lesions with EUS. Gastrointest Endosc. 2004;59:698–707.

    Article  PubMed  Google Scholar 

  79. Sedlack R, Affi A, Vazquez-Sequeiros E, et al. Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointest Endosc. 2002;56:543–7.

    Article  PubMed  Google Scholar 

  80. Brugge WR, Lauwers GY, Sahani D, et al. Cystic neoplasms of the pancreas. N Engl J Med. 2004;351(12):1218–26.

    Article  PubMed  CAS  Google Scholar 

  81. Sakorafas GH, Sarr MG. Cystic neoplasms of the pancreas: what a clinician should know. Cancer Treat Rev. 2005;31:507–35.

    Article  PubMed  Google Scholar 

  82. Tseng JF, Warshaw AL, Sahani DV, et al. Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg. 2005;242:413–19.

    PubMed  Google Scholar 

  83. Walsh RM, Vogt DP, Henderson JM, et al. Natural history of indeterminate pancreatic cysts. Surgery. 2005;138:665–71.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Instituto Nacional de la Nutrición Salvador Zubirán, Mexico City, Mexico

    Miguel F. Herrera, Juan Pablo Pantoja, Mauricio Sierra Salazar & David Velázquez-Fernández

Authors
  1. Miguel F. Herrera
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juan Pablo Pantoja
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mauricio Sierra Salazar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Velázquez-Fernández
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. St Thomas Hospital, Lambeth Palace Road, London SE1 7EH, United Kingdom

    Johnathan Hubbard

  2. Coll Physicians & Surgeons Columbia, Fort Washington Avenue 161, New York, 10032, U.S.A.

    William B. Inabnet

  3. Queen Mary Hospital, University of Hong Kong Medical Centre, Pokfulam, Hong Kong, China, People's Republic

    Chung-Yau Lo

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag London Limited

About this chapter

Cite this chapter

Herrera, M.F., Pantoja, J.P., Salazar, M.S., Velázquez-Fernández, D. (2009). Pancreatic Incidentaloma. In: Hubbard, J., Inabnet, W., Lo, CY. (eds) Endocrine Surgery. Springer Specialist Surgery Series. Springer, London. https://doi.org/10.1007/978-1-84628-881-4_41

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-881-4_41

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-880-7

  • Online ISBN: 978-1-84628-881-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation